Aberrant Accumulation of Cyclin D1 Rewires Glutamine Metabolism and Generates a Metabolic Vulnerability in Squamous Cell Carcinoma.

Cyclin D1 accumulation rewires glutamine metabolism, creating a metabolic vulnerability in squamous cell carcinoma with a significant dependence on glutamine.

• Why it matters: Understanding how cyclin D1 dysregulation alters tumor metabolism can reveal new therapeutic targets for cancers resistant to standard treatments, addressing a critical gap in cancer therapy.
• What they did: Researchers used molecular and cellular approaches to show that nuclear cyclin D1 activates CDK4/6 and downregulates IDH3, leading to increased glutamine dependence and autophagy in squamous cell carcinoma models.
• The result: Co-targeting autophagy and glutamine metabolism effectively suppressed tumor growth in vitro and in vivo, suggesting a promising strategy to exploit metabolic vulnerabilities in cyclin D1-driven cancers.